ICAD News and Press, iCad Inc. From 03/14/24

2024-03-14 14:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The market is overlooking many stocks that could benefit from the proliferation of AI over the longer term. There are companies using AI to solve real-world problems, and others providing the r...

2024-03-12 22:59:05 ET iCAD, Inc. (ICAD) Q4 2023 Earnings Conference Call March 12, 2024 16:30 ET Corporate Participants Jeremiah Bennett - Vice President, Marketing Dana Brown - President and Chief Executive Officer Eric Lonnqvist - Chief Financial Officer. ...

2024-03-12 16:02:27 ET More on iCAD ICAD stock jumps 11% ahead of medical meeting presentations Seeking Alpha’s Quant Rating on iCAD Historical earnings data for iCAD Financial information for iCAD Read the full article on Seeking Alpha ...

Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-year Full-Year Operating Cash Flow ($5) million vs. ($12.8) million prior year Year ending cash balance of $21.7M NASHUA, N.H., March 12, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global ...

Koninklijke KPN NV (KKPNF) is expected to report for Q4 2023 ECA Marcellus Trust I Unit (ECTM) is expected to report for Q4 2023 San Juan Basin Royalty Trust (SJT) is expected to report for Q4 2023 Avenir Wellness Solutions Inc (AVRW) is expected to report for Q4 2023 Carmell Corp...

2024-03-01 07:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wall Street has correctly recognized that artificial intelligence ( AI ) is a game-changer. It enables individuals to use computers more easily than ever before to find the best answers to ...

Clinical evidence demonstrates ProFound Detection’s AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional false negatives Findings reveal substantially lower radiology reading workload Detection of Breast Arterial Calcific...

NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, announced today the appointment of Dr. Hricak ...

NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, announced today the Company will release financial resul...

NASHUA, N.H., Feb. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, announced today the Company will participate in the BTI...